Exact Mass: 545.3246882000001
Exact Mass Matches: 545.3246882000001
Found 475 metabolites which its exact mass value is equals to given mass value 545.3246882000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Americine
Americine is found in tea. Americine is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea Alkaloid from the root bark of Ceanothus americanus (New Jersey tea). Americine is found in tea.
LysoPC(20:3(5Z,8Z,11Z)/0:0)
C28H52NO7P (545.3481211999999)
LysoPC(20:3(5Z,8Z,11Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:3(5Z,8Z,11Z)), in particular, consists of one chain of mead acid at the C-1 position. The mead acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
LysoPC(20:3(8Z,11Z,14Z)/0:0)
C28H52NO7P (545.3481211999999)
LysoPC(20:3(8Z,11Z,14Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:3(8Z,11Z,14Z)), in particular, consists of one chain of homo-g-linolenic acid at the C-1 position. The homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
Cholylhistidine
Cholylhistidine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylhistidine consists of the bile acid cholic acid conjugated to the amino acid Histidine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylhistidine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylhistidine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
12,13-epoxy-22S,25S,5alpha-veratranine-3beta,17,23alpha-triol-6-one N,O(3)-diacetate
Arg Gln Asp Lys
Asp Arg Lys Lys
Arg Ser Lys Arg
Lys Asn Arg Glu
Val Tyr His Lys
C26H39N7O6 (545.2961674000001)
Asp Ile Ile Trp
Asp Ile Leu Trp
Asp Ile Trp Ile
Asp Ile Trp Leu
Asp Lys Lys Arg
Asp Lys Gln Arg
Asp Lys Arg Lys
Asp Lys Arg Gln
Asp Leu Ile Trp
Asp Leu Leu Trp
Asp Leu Trp Ile
Asp Leu Trp Leu
Asp Gln Lys Arg
Asp Gln Arg Lys
Asp Arg Lys Gln
Asp Arg Gln Lys
Asp Trp Ile Ile
Asp Trp Ile Leu
Asp Trp Leu Ile
Asp Trp Leu Leu
Glu Glu Ile Arg
Glu Glu Leu Arg
Glu Glu Arg Ile
Glu Glu Arg Leu
Glu Ile Glu Arg
Glu Ile Arg Glu
Glu Ile Val Trp
Glu Ile Trp Val
Glu Lys Asn Arg
Glu Lys Arg Asn
Glu Leu Glu Arg
Glu Leu Arg Glu
Glu Leu Val Trp
Glu Leu Trp Val
Glu Asn Lys Arg
Glu Asn Arg Lys
Glu Arg Glu Ile
Glu Arg Glu Leu
Glu Arg Ile Glu
Glu Arg Lys Asn
Glu Arg Leu Glu
Glu Arg Asn Lys
Glu Val Ile Trp
Glu Val Leu Trp
Glu Val Trp Ile
Glu Val Trp Leu
Glu Trp Ile Val
Glu Trp Leu Val
Glu Trp Val Ile
Glu Trp Val Leu
Gly Lys Arg Trp
Gly Lys Trp Arg
Gly Arg Lys Trp
Gly Arg Trp Lys
Gly Trp Lys Arg
Gly Trp Arg Lys
His His Pro Arg
His His Arg Pro
His Lys Val Tyr
C26H39N7O6 (545.2961674000001)
His Lys Tyr Val
C26H39N7O6 (545.2961674000001)
His Pro His Arg
His Pro Arg His
His Arg His Pro
His Arg Pro His
His Val Lys Tyr
C26H39N7O6 (545.2961674000001)
His Val Tyr Lys
C26H39N7O6 (545.2961674000001)
His Tyr Lys Val
C26H39N7O6 (545.2961674000001)
His Tyr Val Lys
C26H39N7O6 (545.2961674000001)
Ile Asp Ile Trp
Ile Asp Leu Trp
Ile Asp Trp Ile
Ile Asp Trp Leu
Ile Glu Glu Arg
Ile Glu Arg Glu
Ile Glu Val Trp
Ile Glu Trp Val
Ile Ile Asp Trp
Ile Ile Trp Asp
Ile Leu Asp Trp
Ile Leu Trp Asp
Ile Arg Glu Glu
Ile Val Glu Trp
Ile Val Trp Glu
Ile Trp Asp Ile
Ile Trp Asp Leu
Ile Trp Glu Val
Ile Trp Ile Asp
Ile Trp Leu Asp
Ile Trp Val Glu
Lys Asp Lys Arg
Lys Asp Gln Arg
Lys Asp Arg Lys
Lys Asp Arg Gln
Lys Glu Asn Arg
Lys Glu Arg Asn
Lys Gly Arg Trp
Lys Gly Trp Arg
Lys His Val Tyr
C26H39N7O6 (545.2961674000001)
Lys His Tyr Val
C26H39N7O6 (545.2961674000001)
Lys Lys Asp Arg
Lys Lys Arg Asp
Lys Asn Glu Arg
Lys Asn Val Trp
C26H39N7O6 (545.2961674000001)
Lys Asn Trp Val
C26H39N7O6 (545.2961674000001)
Lys Gln Asp Arg
Lys Gln Arg Asp
Lys Arg Asp Lys
Lys Arg Asp Gln
Lys Arg Glu Asn
Lys Arg Gly Trp
Lys Arg Lys Asp
Lys Arg Asn Glu
Lys Arg Gln Asp
Lys Arg Arg Ser
Lys Arg Ser Arg
Lys Arg Trp Gly
Lys Ser Arg Arg
Lys Val His Tyr
C26H39N7O6 (545.2961674000001)
Lys Val Asn Trp
C26H39N7O6 (545.2961674000001)
Lys Val Trp Asn
C26H39N7O6 (545.2961674000001)
Lys Val Tyr His
C26H39N7O6 (545.2961674000001)
Lys Trp Gly Arg
Lys Trp Asn Val
C26H39N7O6 (545.2961674000001)
Lys Trp Arg Gly
Lys Trp Val Asn
C26H39N7O6 (545.2961674000001)
Lys Tyr His Val
C26H39N7O6 (545.2961674000001)
Lys Tyr Val His
C26H39N7O6 (545.2961674000001)
Leu Asp Ile Trp
Leu Asp Leu Trp
Leu Asp Trp Ile
Leu Asp Trp Leu
Leu Glu Glu Arg
Leu Glu Arg Glu
Leu Glu Val Trp
Leu Glu Trp Val
Leu Ile Asp Trp
Leu Ile Trp Asp
Leu Leu Asp Trp
Leu Leu Trp Asp
Leu Arg Glu Glu
Leu Val Glu Trp
Leu Val Trp Glu
Leu Trp Asp Ile
Leu Trp Asp Leu
Leu Trp Glu Val
Leu Trp Ile Asp
Leu Trp Leu Asp
Leu Trp Val Glu
Asn Glu Lys Arg
Asn Glu Arg Lys
Asn Lys Glu Arg
Asn Lys Arg Glu
Asn Lys Val Trp
C26H39N7O6 (545.2961674000001)
Asn Lys Trp Val
C26H39N7O6 (545.2961674000001)
Asn Arg Glu Lys
Asn Arg Lys Glu
Asn Arg Arg Thr
C20H39N11O7 (545.3033783999999)
Asn Arg Thr Arg
C20H39N11O7 (545.3033783999999)
Asn Thr Arg Arg
C20H39N11O7 (545.3033783999999)
Asn Val Lys Trp
C26H39N7O6 (545.2961674000001)
Asn Val Trp Lys
C26H39N7O6 (545.2961674000001)
Asn Trp Lys Val
C26H39N7O6 (545.2961674000001)
Asn Trp Val Lys
C26H39N7O6 (545.2961674000001)
Pro His His Arg
Pro His Arg His
Pro Arg His His
Gln Asp Lys Arg
Gln Asp Arg Lys
Gln Lys Asp Arg
Gln Lys Arg Asp
Gln Arg Asp Lys
Gln Arg Lys Asp
Gln Arg Arg Ser
C20H39N11O7 (545.3033783999999)
Gln Arg Ser Arg
C20H39N11O7 (545.3033783999999)
Gln Ser Arg Arg
C20H39N11O7 (545.3033783999999)
Arg Asp Lys Lys
Arg Asp Lys Gln
Arg Asp Gln Lys
Arg Glu Glu Ile
Arg Glu Glu Leu
Arg Glu Ile Glu
Arg Glu Lys Asn
Arg Glu Leu Glu
Arg Glu Asn Lys
Arg Gly Lys Trp
Arg Gly Trp Lys
Arg His His Pro
Arg His Pro His
Arg Ile Glu Glu
Arg Lys Asp Lys
Arg Lys Asp Gln
Arg Lys Glu Asn
Arg Lys Gly Trp
Arg Lys Lys Asp
Arg Lys Asn Glu
Arg Lys Gln Asp
Arg Lys Arg Ser
Arg Lys Ser Arg
Arg Lys Trp Gly
Arg Leu Glu Glu
Arg Asn Glu Lys
Arg Asn Lys Glu
Arg Asn Arg Thr
C20H39N11O7 (545.3033783999999)
Arg Asn Thr Arg
C20H39N11O7 (545.3033783999999)
Arg Pro His His
Arg Gln Lys Asp
Arg Gln Arg Ser
C20H39N11O7 (545.3033783999999)
Arg Gln Ser Arg
C20H39N11O7 (545.3033783999999)
Arg Arg Lys Ser
Arg Arg Asn Thr
C20H39N11O7 (545.3033783999999)
Arg Arg Gln Ser
C20H39N11O7 (545.3033783999999)
Arg Arg Ser Lys
Arg Arg Ser Gln
C20H39N11O7 (545.3033783999999)
Arg Arg Thr Asn
C20H39N11O7 (545.3033783999999)
Arg Ser Gln Arg
C20H39N11O7 (545.3033783999999)
Arg Ser Arg Lys
Arg Ser Arg Gln
C20H39N11O7 (545.3033783999999)
Arg Thr Asn Arg
C20H39N11O7 (545.3033783999999)
Arg Thr Arg Asn
C20H39N11O7 (545.3033783999999)
Arg Trp Gly Lys
Arg Trp Lys Gly
Ser Lys Arg Arg
Ser Gln Arg Arg
C20H39N11O7 (545.3033783999999)
Ser Arg Lys Arg
Ser Arg Gln Arg
C20H39N11O7 (545.3033783999999)
Ser Arg Arg Lys
Ser Arg Arg Gln
C20H39N11O7 (545.3033783999999)
Thr Asn Arg Arg
C20H39N11O7 (545.3033783999999)
Thr Arg Asn Arg
C20H39N11O7 (545.3033783999999)
Thr Arg Arg Asn
C20H39N11O7 (545.3033783999999)
Val Glu Ile Trp
Val Glu Leu Trp
Val Glu Trp Ile
Val Glu Trp Leu
Val His Lys Tyr
C26H39N7O6 (545.2961674000001)
Val His Tyr Lys
C26H39N7O6 (545.2961674000001)
Val Ile Glu Trp
Val Ile Trp Glu
Val Lys His Tyr
C26H39N7O6 (545.2961674000001)
Val Lys Asn Trp
C26H39N7O6 (545.2961674000001)
Val Lys Trp Asn
C26H39N7O6 (545.2961674000001)
Val Lys Tyr His
C26H39N7O6 (545.2961674000001)
Val Leu Glu Trp
Val Leu Trp Glu
Val Asn Lys Trp
C26H39N7O6 (545.2961674000001)
Val Asn Trp Lys
C26H39N7O6 (545.2961674000001)
Val Trp Glu Ile
Val Trp Glu Leu
Val Trp Ile Glu
Val Trp Lys Asn
C26H39N7O6 (545.2961674000001)
Val Trp Leu Glu
Val Trp Asn Lys
C26H39N7O6 (545.2961674000001)
Val Tyr Lys His
C26H39N7O6 (545.2961674000001)
Trp Asp Ile Ile
Trp Asp Ile Leu
Trp Asp Leu Ile
Trp Asp Leu Leu
Trp Glu Ile Val
Trp Glu Leu Val
Trp Glu Val Ile
Trp Glu Val Leu
Trp Gly Lys Arg
Trp Gly Arg Lys
Trp Ile Asp Ile
Trp Ile Asp Leu
Trp Ile Glu Val
Trp Ile Ile Asp
Trp Ile Leu Asp
Trp Ile Val Glu
Trp Lys Gly Arg
Trp Lys Asn Val
C26H39N7O6 (545.2961674000001)
Trp Lys Arg Gly
Trp Lys Val Asn
C26H39N7O6 (545.2961674000001)
Trp Leu Asp Ile
Trp Leu Asp Leu
Trp Leu Glu Val
Trp Leu Ile Asp
Trp Leu Leu Asp
Trp Leu Val Glu
Trp Asn Lys Val
C26H39N7O6 (545.2961674000001)
Trp Asn Val Lys
C26H39N7O6 (545.2961674000001)
Trp Arg Gly Lys
Trp Arg Lys Gly
Trp Val Glu Ile
Trp Val Glu Leu
Trp Val Ile Glu
Trp Val Lys Asn
C26H39N7O6 (545.2961674000001)
Trp Val Leu Glu
Trp Val Asn Lys
C26H39N7O6 (545.2961674000001)
Tyr His Lys Val
C26H39N7O6 (545.2961674000001)
Tyr His Val Lys
C26H39N7O6 (545.2961674000001)
Tyr Lys His Val
C26H39N7O6 (545.2961674000001)
Tyr Lys Val His
C26H39N7O6 (545.2961674000001)
Tyr Val His Lys
C26H39N7O6 (545.2961674000001)
Tyr Val Lys His
C26H39N7O6 (545.2961674000001)
1-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine
C28H52NO7P (545.3481211999999)
PC(20:3(8Z,11Z,14Z)/0:0)
C28H52NO7P (545.3481211999999)
LysoPC (20:3/0:0)
Colforsin daropate hydrochloride
C27H44ClNO8 (545.2755294000001)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D007155 - Immunologic Factors
Amyloid β-Protein (31-35)
C25H47N5O6S (545.3246882000001)
β-Amyloid (31-35) is the shortest sequence of native Amyloid-β peptide that retains neurotoxic activity.
Methylpendolmycin-14-O-alpha-glucoside
A natural product found in Marinactinospora thermotolerans.
1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
2-[(1S,4R,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-acetyloxy-1,4-dimethoxy-5b,8,8,11a,13a-pentamethyl-3-oxo-4,5,5a,6,7,7a,9,10,11,11b,12,13-dodecahydro-1H-phenanthro[2,1-e]isoindol-2-yl]acetic acid
1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2R,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-[4-oxanyl(oxo)methyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
C27H42F3N3O5 (545.3076398000001)
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2R,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2R,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2S,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
N-[(2S,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
C28H43N5O6 (545.3213178000001)
1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea
[2-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H52NO7P (545.3481211999999)
2-amino-3-[hydroxy-[2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]phosphoryl]oxypropanoic acid
[2-butanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H52NO7P (545.3481211999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] heptanoate
C28H52NO7P (545.3481211999999)
[2-acetyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H52NO7P (545.3481211999999)
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] propanoate
C28H52NO7P (545.3481211999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] pentanoate
C28H52NO7P (545.3481211999999)
(E)-(3R)-(1R,2S,5R)-8-beta-Naphthylmenthyl 3-benzylamino-5-phenyl-4-pentenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[(2R)-2-hydroxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H52NO7P (545.3481211999999)
[(2R)-2-hydroxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H52NO7P (545.3481211999999)
2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxynonadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-Meadoyl-sn-glycero-3-phosphocholine
C28H52NO7P (545.3481211999999)
A lysophosphatidylcholine 20:3 in which the acyl group at position 1 is (5Z,8Z,11Z)-icosatrienoyl (meadoyl) and the hydroxy group at position 2 is unsubstituted.
1-[(8Z,11Z,14Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
C28H52NO7P (545.3481211999999)
A lysophosphatidylcholine 20:3/0:0 in which the acyl group at position 1 is specified as (8Z,11Z,14Z)-icosatrienoyl.
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoserine
lysophosphatidylcholine (0:0/20:3)
C28H52NO7P (545.3481211999999)
A lysophosphatidylcholine 20:3 in which the acyl group is located at position 2.
lysophosphatidylcholine 20:3
C28H52NO7P (545.3481211999999)
A lysophosphatidylcholine in which the acyl group contains 20 carbons with 3 double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine 20:3/0:0
C28H52NO7P (545.3481211999999)
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group at C-1 contains 20 carbons and 3 double bonds.
MePC(19:3)
C28H52NO7P (545.3481211999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(22:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(19:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
3-methyl-2-({[2,5,8-trihydroxy-3-(2-phenylethyl)-6-(sec-butyl)-1,4,7-triazacyclotrideca-1,4,7-trien-9-yl]-c-hydroxycarbonimidoyl}amino)butanoic acid
C28H43N5O6 (545.3213178000001)
(2-{[(2r)-2-hydroxy-3-[(5z,8z,11z)-icosa-5,8,11-trienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
C28H52NO7P (545.3481211999999)